Clinical Trial Update: A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women [Phase 1]

View source ↗

Summary

Phase 1 single-dose study evaluating romosozumab (AMG 785) in healthy postmenopausal women (Japanese and non-Japanese) with osteopenia; completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2019-07-31